188 related articles for article (PubMed ID: 16974125)
1. [New perspectives in the management of non-small-cell lung carcinoma (NSCLC)].
Brockmöller J; Junker K; Multhoff G
Onkologie; 2006 Sep; 29 Suppl 2():25-8. PubMed ID: 16974125
[No Abstract] [Full Text] [Related]
2. [Surgery and adjuvant therapy in non-small-cell lung carcinoma (NSCLC). (stage I through operable stage IIIA)].
Eberhardt W; Fietkau R; Griesinger F; Passlick B; Stuschke M
Onkologie; 2006 Sep; 29 Suppl 2():7-10. PubMed ID: 16974121
[No Abstract] [Full Text] [Related]
3. [Diagnosis of non-small-cell lung carcinoma (NSCLC)].
Herth F; Kirsch CM; Stoelben E
Onkologie; 2006 Sep; 29 Suppl 2():3-6. PubMed ID: 16974120
[No Abstract] [Full Text] [Related]
4. [Pillnitz interdisciplinary discussion--summary].
Gatzemeier U; Griesinger F; Huber RM
Onkologie; 2006 Sep; 29 Suppl 2():2. PubMed ID: 16974119
[No Abstract] [Full Text] [Related]
5. [Therapy in non-small-cell lung carcinoma (NSCLC) in local advanced stage (inoperable IIIA/IIIB)].
Baumann M; Dienemann HC; Fietkau R; Rübe C; Thomas M
Onkologie; 2006 Sep; 29 Suppl 2():11-4. PubMed ID: 16974122
[No Abstract] [Full Text] [Related]
6. [Expression of MAGE-3 gene product in non-small cell lung cancer].
Liu Q; Zhang C; Feng K
Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):138-40. PubMed ID: 11776642
[TBL] [Abstract][Full Text] [Related]
7. [P27 expression and survival in NSCLC].
Hirabayashi H
Nihon Rinsho; 2002 May; 60 Suppl 5():263-6. PubMed ID: 12101669
[No Abstract] [Full Text] [Related]
8. [Therapy for non-small-cell lung carcinoma (NSCLC) in stage IV].
Deppermann KM; Huber RM; Laack E; Reck M; Serke M; von Pawel J
Onkologie; 2006 Sep; 29 Suppl 2():15-9. PubMed ID: 16974123
[No Abstract] [Full Text] [Related]
9. Non-small-cell lung cancer: then and now.
Schiller JH; Gandara DR; Goss GD; Vokes EE
J Clin Oncol; 2013 Mar; 31(8):981-3. PubMed ID: 23401450
[No Abstract] [Full Text] [Related]
10. Epidermal growth factor receptor biomarkers in non-small-cell lung cancer: a riddle, wrapped in a mystery, inside an enigma.
Shepherd FA; Tsao MS
J Clin Oncol; 2010 Feb; 28(6):903-5. PubMed ID: 20100955
[No Abstract] [Full Text] [Related]
11. [Concept of quality assurance in the management of lung carcinoma].
Blankenburg T; Flentje M; Friedel G; Huber RM; Tesch H
Onkologie; 2006 Sep; 29 Suppl 2():20-4. PubMed ID: 16974124
[No Abstract] [Full Text] [Related]
12. Template for reporting results of biomarker testing of specimens from patients with non-small cell carcinoma of the lung.
Cagle PT; Sholl LM; Lindeman NI; Alsabeh R; Divaris DX; Foulis P; Lee G; Neal JW; Nowak JA; Yu PP;
Arch Pathol Lab Med; 2014 Feb; 138(2):171-4. PubMed ID: 23808401
[No Abstract] [Full Text] [Related]
13. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group.
Richardson GE; Thursfield VJ; Giles GG
Med J Aust; 2000 Apr; 172(7):321-4. PubMed ID: 10844918
[TBL] [Abstract][Full Text] [Related]
14. Molecular staging and the selection of therapy for non-small cell lung cancer.
D'Amico TA
Semin Thorac Cardiovasc Surg; 2005; 17(3):180-5. PubMed ID: 16253819
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of non-small-cell lung cancer.
Lacroix L; Commo F; Soria JC
Expert Rev Mol Diagn; 2008 Mar; 8(2):167-78. PubMed ID: 18366303
[TBL] [Abstract][Full Text] [Related]
16. Practice guidelines for non-small cell lung cancer.
Cameron R; Fringer J; Taylor C; Gilden CR; Figlin RA
Cancer J Sci Am; 1996; 2(3A Suppl):S61-8. PubMed ID: 9166525
[No Abstract] [Full Text] [Related]
17. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy.
Osmani L; Askin F; Gabrielson E; Li QK
Semin Cancer Biol; 2018 Oct; 52(Pt 1):103-109. PubMed ID: 29183778
[TBL] [Abstract][Full Text] [Related]
18. Re: Gene expression-based prognostic signatures in lung cancer: ready for clinical use?
Boutros PC; Pintilie M; John T; Starmans MH; Der SD; Shepherd FA; Tsao MS; Jurisica I
J Natl Cancer Inst; 2010 Nov; 102(21):1677-8; author reply 1678-9. PubMed ID: 20921041
[No Abstract] [Full Text] [Related]
19. Evaluation of squamous cell carcinoma antigen (SCC-Ag) in the diagnosis and follow-up of patients with non-small cell lung carcinoma.
Nikliński J; Furman M; Laudański J; Kozłowski M
Neoplasma; 1992; 39(5):279-82. PubMed ID: 1331826
[TBL] [Abstract][Full Text] [Related]
20. Biological, molecular, and clinical markers for the diagnosis and typing of lung cancer.
Gazdar AF; Mulshine JL; Kramer BS
Immunol Ser; 1990; 53():453-68. PubMed ID: 1966068
[No Abstract] [Full Text] [Related]
[Next] [New Search]
